|
News :: 3-9-10
|
The consultant
More info...
Clinical Trials
More info...
ED solution
More info...
Medical Europe
Blog
|
|
Our bookstore is open 24/7.
You will find medical reports,
books, abstracts and other interesting publications, on-line.
Visit the
bookstore
|
|
|
Read more about the driving force behind
Medical Europe. See how a vast network of contacts throughout
the European Medical community can help you and your company secure a firm
foothold in the European community.
click here.
|
|
|
|
What can you expect from the 4th Medicial Clinic Targu Mures, Romania ?
|
The 4th Medicial Clinic Targu Mures, Romania, is a
research intensive academic institution with busy in- and outpatient
departements focused on cardiology and internal medecine.
Our medical, research and administrative staff offer the expertise
needed to make clinical trials a success for sponsors and patients.
We are experienced in phase II-IV international clinical trials and
we are looking for partners interested in research cooperation.
Main therapeutic areas / diagnostic facilities:
Coronary artery disease / stress test / coronarography
Heart failure / echocardiography
Hypertension / 24 h ABPM
Syncope / tilt testing
Arrhythmias / Holter ECG, electrophysiological study
Peripheral vascular diseases / Doppler
Beside our own research themes, we participated in the
following international trials:
AMISTAD
Adenosine as an adjunct to thrombolytic therapy for acute
myocardial infarction: results of a multicenter, randomized,
placebo-controlled trial: the Acute Myocardial Infarction STudy of
Adenosine (AMISTAD) trial.
Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar
MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V,
Orlandi C, Blevins R, Gibbons RJ, Califf RM, Granger CB
J Am Coll Cardiol. 1999 Nov 15;34(6):1711-20
EPHESUS (ongoing)
The EPHESUS trial: eplerenone in patients with heart
failure due to systolic dysfunction complicating acute myocardial
infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival
Study.
Pitt B, Williams G, Remme W, Martinez F, Lopez-Sendon J,
Zannad F, Neaton J, Roniker B, Hurley S, Burns D, Bittman R, Kleiman J
Cardiovasc Drugs Ther. 2001 Jan;15(1):79-87
SENIORS
Study of the Effects of Nebivolol Intervention on Outcomes
and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and
design.
Shibata MC, Flather MD, Bohm M, Borbola J, Cohen-Solal A,
Dumitrascu D, Ferrari R, Lechat P, Parkhomenko A, Soler-Soler J, Tavazzi L,
Toman J, Van Veldhuisen DJ, Coats AJ, Poole-Wilson P; Study of the Effects of
Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart
Failure.
Int J Cardiol. 2002 Nov;86(1):77-85
PREVENT
Rationale and design of a clinical trial of a
low-molecular-weight heparin in preventing clinically important venous
thromboembolism in medical patients: the prospective evaluation of dalteparin
efficacy for prevention of venous thromboembolism in immobilized patients trial
(the PREVENT study).
Vaitkus PT, Leizorovicz A, Goldhaber SZ; PREVENT
Investigator Group.
Vasc Med. 2002;7(4):269-73
|
|
The 4th Medical Clinic and its outpatient
departement is affiliated to the County Emergency Hospital and to the
University of Medicine and Pharmacy Targu
Mures, being located in the University campus.
|
________________________________________
For more information please contact:
Cristian Podoleanu MD, PhD
Specialist in cardiology and internal medicine Assistant Professor
Cardiology Department - 4th Medical Clinic
University Clinic Hospital Targu Mures
Romania
emailadres: pcristi@gmx.de
|
|
|
|
|